REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,823,700 | +17.6% | 369,648 | +72.0% | 0.10% | +5.1% |
| Q3 2022 | $5,803,000 | +94.0% | 214,935 | -0.7% | 0.10% | +115.2% |
| Q2 2022 | $2,992,000 | -31.0% | 216,470 | -2.7% | 0.05% | -16.4% |
| Q1 2022 | $4,337,000 | -8.1% | 222,408 | -23.1% | 0.06% | 0.0% |
| Q4 2021 | $4,719,000 | -44.3% | 289,124 | -5.0% | 0.06% | -47.6% |
| Q3 2021 | $8,477,000 | -17.1% | 304,272 | -11.8% | 0.10% | -13.2% |
| Q2 2021 | $10,227,000 | -4.7% | 345,031 | -10.1% | 0.12% | -8.3% |
| Q1 2021 | $10,728,000 | -11.9% | 383,828 | -10.7% | 0.13% | -15.9% |
| Q4 2020 | $12,182,000 | +10.6% | 429,836 | -1.9% | 0.16% | -20.7% |
| Q3 2020 | $11,019,000 | -6.7% | 438,321 | -9.4% | 0.20% | +13.8% |
| Q2 2020 | $11,809,000 | +66.1% | 483,576 | +0.7% | 0.17% | +56.8% |
| Q1 2020 | $7,109,000 | -21.8% | 480,367 | -14.2% | 0.11% | +18.1% |
| Q4 2019 | $9,085,000 | +1892.3% | 559,764 | +1496.7% | 0.09% | +1780.0% |
| Q3 2019 | $456,000 | +28.1% | 35,057 | +27.8% | 0.01% | +25.0% |
| Q2 2019 | $356,000 | -18.5% | 27,421 | -1.1% | 0.00% | -20.0% |
| Q1 2019 | $437,000 | -56.1% | 27,712 | -43.9% | 0.01% | -58.3% |
| Q4 2018 | $995,000 | -18.0% | 49,441 | +1.2% | 0.01% | 0.0% |
| Q3 2018 | $1,214,000 | +6.4% | 48,851 | +17.6% | 0.01% | 0.0% |
| Q2 2018 | $1,141,000 | -16.7% | 41,552 | -6.6% | 0.01% | -20.0% |
| Q1 2018 | $1,370,000 | -22.3% | 44,478 | -9.8% | 0.02% | -21.1% |
| Q4 2017 | $1,763,000 | +20.8% | 49,301 | -7.0% | 0.02% | +18.8% |
| Q3 2017 | $1,460,000 | +2.1% | 53,008 | -2.1% | 0.02% | 0.0% |
| Q2 2017 | $1,430,000 | +21.5% | 54,166 | -4.3% | 0.02% | +23.1% |
| Q1 2017 | $1,177,000 | -6.4% | 56,610 | -6.9% | 0.01% | -18.8% |
| Q4 2016 | $1,258,000 | +618.9% | 60,786 | +462.4% | 0.02% | +433.3% |
| Q3 2016 | $175,000 | +22.4% | 10,808 | +2.6% | 0.00% | 0.0% |
| Q2 2016 | $143,000 | – | 10,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |